|
|
||||||||



* School of Biomedical & Life Sciences, University of Surrey, Guildford, United Kingdom
School of Food Biosciences, University of Reading, Reading, United Kingdom
Centre of Cardiovascular Genetics, University College London, London, United Kingdom
** European Institute of Health & Medical Sciences, University of Surrey, Guildford, United Kingdom
1 To whom correspondence should be addressed. e-mail: b.griffin{at}surrey.ac.uk
We sought to test the hypothesis that dietary long-chain n-3 PUFA (LC n-3 PUFA) in fish oil stimulate the gene expression of lipoprotein lipase (LPL) in human adipose tissue (AT). In a randomized, double blind, placebo-controlled, cross-over study, 51 male subjects expressing an atherogenic lipoprotein phenotype (ALP) had their diets supplemented with fish oil for 6 weeks. As we previously reported for this group, supplementation with LC n-3 PUFA produced a decrease in fasting plasma triglyceride (TG) (-35%, P < 0.05), attenuation of the postprandial TG response (area and incremental area under the curve; AUC and IAUC, P < 0.05), and a decrease in small, dense LDL. The present study extended these observations by showing that these changes were accompanied by a marked increase in the concentration of LPL mRNA in adipose tissue (AT-LPL mRNA, +55%, P = 0.003) and post-heparin LPL activity (PH-LPL, +31%, P = 0.036). There was also evidence of an association between LPL gene expression and polymorphism in the apolipoprotein E gene.
We conclude that the favorable influence of dietary n-3 PUFA on the ALP may be mediated, in part, through an increase in the plasma activity and gene expression of lipoprotein lipase in human adipose tissue.
Abbreviations: ALP, atherogenic lipoprotein phenotype; AT, adipose tissue; AUC, area under curve; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; IAUC, incremental area under the curve; LC, long-chain; PH-LPL, post-heparin lipoprotein lipase; TG, triglycerides
Supplementary key words polyunsaturated fatty acids lipoprotein lipase gene fish oil
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
T. A Jacobson Role of n-3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease Am. J. Clinical Nutrition, June 1, 2008; 87(6): 1981S - 1990S. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. J. Jung, C. Torrejon, A. P Tighe, and R. J Deckelbaum n-3 Fatty acids and cardiovascular disease: mechanisms underlying beneficial effects Am. J. Clinical Nutrition, June 1, 2008; 87(6): 2003S - 2009S. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Aktas and J. A. Halperin Translational Regulation of Gene Expression by {omega}-3 Fatty Acids J. Nutr., September 1, 2004; 134(9): 2487S - 2491S. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Park, P. G Jones, and W. S Harris Triacylglycerol-rich lipoprotein margination: a potential surrogate for whole-body lipoprotein lipase activity and effects of eicosapentaenoic and docosahexaenoic acids Am. J. Clinical Nutrition, July 1, 2004; 80(1): 45 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Park and W. S. Harris Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance J. Lipid Res., March 1, 2003; 44(3): 455 - 463. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |